Russell Investments Group, Ltd. Vincerx Pharma, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.0 - $1.72 $0 - $354,705	206,224 New	206,224 $284,000
Q2 2022 Jul 29, 2022	SELL	$0.0 - $0.0 $0 - $0	-226,931 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$0.0 - $0.0 $0 - $0	163,481 Added 257.65%	226,931 $906,000
Q4 2021 Jan 21, 2022	BUY	$0.0 - $0.0 $0 - $0	6,934 Added 12.27%	63,450 $644,000
Q3 2021 Nov 08, 2021	SELL	$0.0 - $0.0 $0 - $0	-3,224 Reduced 5.4%	56,516 $912,000
Q2 2021 Aug 04, 2021	BUY	$0.0 - $27.0 $0 - $1.61 Million	59,740 New	59,740 $775,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.